Recent News

• 09.30.2025 - Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP)
• 09.30.2025 - Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP)
• 09.10.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.10.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.09.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.09.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.04.2025 - 2025 Wells Fargo Healthcare Conference
• 09.04.2025 - 2025 Wells Fargo Healthcare Conference
• 09.03.2025 - Cantor Fitzgerald Global Healthcare Conference
• 09.03.2025 - Cantor Fitzgerald Global Healthcare Conference

Recent Filings

• 09.15.2025 - 8-K Current report
• 09.03.2025 - 8-K Current report
• 08.22.2025 - 8-K Current report
• 08.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors